Out-licensing: a practical approach for improvement of access to medicines in poor countries.
作者信息
Friedman Michael A, den Besten Henk, Attaran Amir
机构信息
Pharmacia Corporation, Peapack, NJ, USA.
出版信息
Lancet. 2003 Jan 25;361(9354):341-4. doi: 10.1016/S0140-6736(03)12331-8.
Abstract
摘要
相似文献
1
Out-licensing: a practical approach for improvement of access to medicines in poor countries.对外许可：改善贫困国家药品可及性的实用方法。
Lancet. 2003 Jan 25;361(9354):341-4. doi: 10.1016/S0140-6736(03)12331-8.
2
Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.专利绊脚：艾滋病、治疗可及性与制造稀缺
Conn J Int Law. 2002 Spring;17(2):157-248.
3
Academic patents and access to medicines in developing countries.学术专利与发展中国家的药品可及性。
Am J Public Health. 2009 Jan;99(1):9-17. doi: 10.2105/AJPH.2007.128769. Epub 2008 Nov 13.
4
Patent immorality?专利不道德行为？
Am J Bioeth. 2002 Summer;2(3):48-9. doi: 10.1162/152651602760250156.
5
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
6
Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues.知识产权、强制许可与《与贸易有关的知识产权协定》：若干伦理问题。
Monash Bioeth Rev. 2003 Apr;22(2):63-8.
7
TRIPS, pharmaceuticals, developing countries, and the Doha "solution".《与贸易有关的知识产权协定》、药品、发展中国家与多哈“解决方案”
Chic J Int Law. 2002 Spring;3(1):47-68.
8
The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.世贸组织争端解决谅解：抗击艾滋病的一件不太可能的武器。
Am J Law Med. 2001;27(4):469-85.
9
More drugs, less protection.药物越多，保护越少。
Nature. 2002 Sep 19;419(6904):233. doi: 10.1038/419233a.
10
Are rich nations up for drug reform?富裕国家准备好进行毒品改革了吗？
Nature. 2006 May 11;441(7090):135. doi: 10.1038/441135a.
引用本文的文献
1
Could patents interfere with the development of a cardiovascular polypill?专利会对心血管复方制剂的研发产生干扰吗？
J Transl Med. 2016 Aug 18;14(1):242. doi: 10.1186/s12967-016-0997-3.
Zotero 插件